Bene probably have manufacturing or utility patents around the whole process, so even if one or more of their scientists jumped ship and took all the IP with them they couldn’t just set up a new facility and start churning it out (even though the product itself is long out of patent).
Or to put it another way, even if some sort of IA application told you exactly how Bene created this molecule, you probably couldn’t replicate the process without infringing one or more of Bene’s patents.
- Forums
- ASX - By Stock
- Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
Bene probably have manufacturing or utility patents around the...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $81.36M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25818 | 0.235 |
8 | 99346 | 0.225 |
6 | 64676 | 0.220 |
8 | 190313 | 0.215 |
14 | 559696 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 141103 | 6 |
0.245 | 72877 | 3 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online